English | Español
Patient Daily | Jun 18, 2026

Biogen to acquire RayThera for up to $1 billion in immunology expansion
Patient Daily | Jun 18, 2026

Verastem deprioritizes pancreatic cancer drug combo after latest trial results
Patient Daily | Jun 18, 2026

Biopharma layoffs linked to company milestones and asset performance, expert says
Patient Daily | Jun 18, 2026

Study links repeated low-level blast exposure to increased anger risk in veterans
Patient Daily | Jun 18, 2026

Study finds breast milk nutrient boosts immune system development in mice and infants
Patient Daily | Jun 18, 2026

Study finds paid paternity leave supports mental health of new fathers
Patient Daily | Jun 18, 2026

Study finds fish oil supplements offer little benefit for Alzheimer's prevention
Patient Daily | Jun 18, 2026

Study finds JAK2 mutation does not always lead to blood cancer

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Regulatory
G. N. Ball | Aug 5, 2026

Citizens Against Government Waste on 340B: 'Covered hospitals now generate millions of dollars of profit'